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INTRODUCTION
Radiopharmaceuticals are radioactive drugs used for diagnostic and therapeutic purposes. Production, control, distribution and
clinical application of radiopharmaceuticals in EU have not been subject to the same regulations and legislation developed for
conventional pharmaceutical products. Generally, regulations of radiopharmaceuticals in Republic of Macedonia are in compliance
with EU regulative, but marketing authorisation is not recognize in practise, although the regulation requires it.
THE AIM: To evaluate the regulations in Republic of Macedonia dealing with radiopharmaceuticals with emphasis on Marketing
authorisation, keeping in mind that the way how radiopharmaceuticals is developed and introduced to the users are completely
different from what was typical for conventional pharmaceutical products.
MACEDONIA BECOMES A REGIONAL 
CENTER FOR ISOTOPES
SPECIFIC ISSUES
The quality of the radiopharmaceuticals is defined in
the applicable EU pharmacopeia monographs of
individual radiopharmaceuticals.
Radiopharmaceuticals could not be considered as
something extraordinary, so the same quality
standards would have to be appled for these products
as for conventional Pharmaceuticals.
Many countries have established national registration procedures to
obtain official market authorisation for a radiopharmaceutical. In
Republic of Macedonia radiopharmaceuticals are included under the
general legislation for medicinal products. Republic of Macedonia is a
small country and usage of radiopharmaceuticals is small. Therefore
the interest in registering these products is limitted.
STATUS OF RADIOPHARMACEUTICAL REGULATIONS
IN REPUBLIC OF MACEDONIA
1. Law on Medicines and Medical Devices (Official gazette No. 106/07,88/2010, 36/11, 53/11, 136/11, 11/12, 147/13, 27/14,
43/14, 88/15) in which radiopharmaceuticals are regulated
2. Rulebook on the contents of the application, the documentation and detailed requirements in respect of the premises,
equipment and staff for granting authorisation for production of medicinal products (Official gazette No. 106/07,88/2010,
36/11, 53/11, 136/11, 11/12, 147/13, 27/14, 43/14, 88/15)
3. Rulebook on Good Manufacturing Practices (fully in a compliance with EudraLex Volume 4 Good Manufacturing Practices
Annex 1 for Manufacture of Sterile Medicinal Products 01/ fully 03/2009, Annex 3 for Manufacture of Radiopharmaceuticals,
Annex 11 for Computerized Systems and Annex 15 for Qualification and validation.
4. Law on Ionizing Radiation Protection and Safety (Official gazette No.48/02, 135/07, 53/11, 164/13, 43/14, 149/15)
CONCLUSION
The Law on medicinal products and medical devices of the Republic of Macedonia is completely in compliance with the EU
regulative. But, it is obvious that the requirements used for non-radioactive drugs could not be applied directly to the
radiopharmaceuticals. It must be recognised that radiopharmaceuticals do not have a measurable pharmacodynamic effect. In
the same time radiopharmaceuticals have a changing composition with time due to the radioactive decay of the ultra-short lived
radionculides, so some thimes it is impossible to perform quality control. Republic of Macedonia must to establish national
registration procedures to obtain official market authorisation for a radiopharmaceutical, taking bearing in mind that recently in
Republic of Macedonia PET centre was established and we have our own production of radiopharmacuticals.
